Texas Original Announces State’s First Medical Cannabis Oral Syringe

Audio By Carbonatix

AUSTIN, Texas--(BUSINESS WIRE)--Oct 9, 2025--

Texas Original, Texas’ leading medical cannabis provider, announced the launch of the state’s first oral syringe, available to patients starting this October. The 0.5 gram syringe offers an alternative to traditional gummies, giving providers more options to curate treatment plans with their patients. The product is the first new offering among Texas’ licensed dispensing organizations following the passage of House Bill 46, which expanded the approved methods of delivery under TCUP.

The syringe features Rick Simpson Oil (RSO), which is wholly derived from Texas Original’s proprietary Texas OG strain. RSO is a full-spectrum extract that includes all the cannabinoids, flavonoids, terpenes, proteins and other potentially beneficial compounds of the cannabis plant that may amplify the therapeutic benefits of THC.

“We committed to expanding access and diversifying our product line under the improved Texas Compassionate Use Program—the RSO syringe delivers on that promise and gives Texans even more choices for symptom relief,” said Nico Richardson, CEO of Texas Original. “This product also reflects our uncompromising focus on safety and quality. Texans deserve the best medical cannabis options available, and they can trust us to deliver them.”

The product is one of the new products available under HB 46 which drastically improved patient access throughout the state by:

• Adding new qualifying conditions, including conditions that cause chronic pain, Crohn’s disease, traumatic brain injury, or a terminal illness or a condition for which a patient is receiving hospice or palliative care.
• Allowing for satellite locations where medicine can be stored, creating more availability for prescription pick-ups.
• Approving the use of aerosol or vapor as a means of administration. These medical products offer immediate relief, which is critical for patients with episodic conditions such as PTSD.

The launch comes as the company prepares to open its state-of-the-art headquarters in Bastrop. The 75,000-square-foot facility will feature expanded cultivation, testing and distribution.

"Opening our Bastrop facility isn't just about expansion—it's about what expansion makes possible," Richardson added. "The RSO syringe is just the beginning of what we can bring to market, faster and with even higher quality standards for Texas patients."

To learn more about whether you or a loved one qualify for medical cannabis, visit the Texas Original website.

About Texas Original

Texas Original is the leading licensed medical cannabis producer in Texas, working alongside physicians to provide the highest quality cannabis medicine to patients and families seeking relief across the state. As fellow Texans, we are dedicated to representing the integrity of this great state with our commitment to quality, consistency and purity in every product we produce. We remain committed to advancing safe, legal access to this powerful medicine. Texas Original is headquartered in Austin, with delivery throughout the entire state. For more information, visit www.texasoriginal.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251009264906/en/

CONTACT: Media Contact:

Emma Chase

Red Fan Communications

[email protected]

512-917-4319

KEYWORD: TEXAS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: CANNABIS PUBLIC POLICY/GOVERNMENT HEALTHCARE REFORM SPECIALTY OTHER NATURAL RESOURCES ALTERNATIVE MEDICINE HEALTH RETAIL NATURAL RESOURCES

SOURCE: Texas Original

Copyright Business Wire 2025.

PUB: 10/09/2025 12:51 PM/DISC: 10/09/2025 12:50 PM

http://www.businesswire.com/news/home/20251009264906/en